Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 4Sarcoma 3Wilms Tumor 2Thyroid Neoplasms 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Multiple Myeloma 2Melanoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Lung Neoplasms 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Ependymoma 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Xanthogranuloma, Juvenile 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rectal Neoplasms 1

Interventions

Temozolomide 3Specimen Handling 2tovorafenib 1spartalizumab 1ribociclib 1pembrolizumab 1lutetium Lu 177 dotatate 1larotrectinib 1balstilimab 1Vaccines 1Receptors, Interleukin-8B 1Radiotherapy 1Pharmacogenomic Variants 1Pharmacogenomic Testing 1PTC596 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Injections 1Immune Checkpoint Inhibitors 1Fluid Therapy 1Everolimus 1Eflornithine 1Diphtheria-Tetanus Vaccine 1Diffusion Tensor Imaging 1Cilengitide 1CLR1404 1CBLC137 1Biopsy 1Automobiles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diffuse Intrinsic Pontine Glioma × larotrectinib × 90 days × Clear all
NCT04655404 2026-03-18

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Nationwide Children's Hospital

Phase EARLY_PHASE1 Recruiting
15 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡